|

Selective estrogen receptor modulator (SERM) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Tamoxifen

Pipeline

Phase 1: 1

Top Sponsors

  • Finn, Olivera, PhD1

Indications

  • Ductal Carcinoma in Situ1
  • Breast Cancer1
  • Cancer1

Pittsburgh, Pennsylvania1 trial

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

UPMC Magee Womens Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.